共 90 条
[1]
Welte T(2012)Clinical and economic burden of community-acquired pneumonia among adults in Europe Thorax 67 71-79
[2]
Torres A(2016)Community-acquired pneumonia. Still a major burden of disease Curr Opin Crit Care 22 477-484
[3]
Nathwani D(2020)Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Lancet 396 1204-1222
[4]
Feldman C(2009)New perspectives on community-acquired pneumonia in 388.406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality Thorax 64 1062-1069
[5]
Anderson R(2010)The impact of a delay in intensive care unit admission for community-acquired pneumonia Eur Respir J 36 826-833
[6]
Ewig S(2017)Lymphopenic community-acquired pneumonia (L-CAP), an immunological phenotype associated with higher risk of mortality EBioMedicine 24 231-236
[7]
Birkner N(2021)Lymphopenia is associated with poor outcomes of patients with community-acquired pneumonia and sepsis OFID 8 848-346
[8]
Strauss R(2019)Lymphocytopenia as a predictor of mortality in patients with ICU-acquired Pneumonia J Clin Med 8 754-818
[9]
Phua J(2019)Impact of lymphocyte and neutrophil counts on mortality risk in severe community-acquired pneumonia with or without septic shock J Clin Med 66 340-1489
[10]
Ngerng WJ(2011)Microbial etiology of community-acquired pneumonia and its relation to severity Thorax 37 806-249